Your browser doesn't support javascript.
loading
Pembrolizumab, lenalidomide and dexamethasone post autologous transplant in patients with high-risk multiple myeloma.
Biran, Noa; Gourna Paleoudis, Elli; Feinman, Rena; Vesole, David H; Zenreich, Joshua; Wang, Shuqi; Ahn, Jaeil; Bansal, Meena; Rowley, Scott; Donato, Michele; Pecora, Andrew L; Richter, Joshua; Anand, Palka; McBride, Laura; Ivanovski, Kristin; Korngold, Robert; Siegel, David S.
Afiliação
  • Biran N; John Theurer Cancer Center, Hackensack Meridian Health, Hackensack, New Jersey, USA.
  • Gourna Paleoudis E; Office of Research Administration, Hackensack Meridian Health, Hackensack, New Jersey, USA.
  • Feinman R; Center for Discovery & Innovation, Hackensack Meridian Health, Institute for Multiple Myeloma, Hackensack, New Jersey, USA.
  • Vesole DH; John Theurer Cancer Center, Hackensack Meridian Health, Hackensack, New Jersey, USA.
  • Wang S; Department of Biostatistics, Bioinformatics, and Biomathematics, Georgetown University, Washington, District of Columbia, USA.
  • Ahn J; Department of Biostatistics, Bioinformatics, and Biomathematics, Georgetown University, Washington, District of Columbia, USA.
  • Bansal M; John Theurer Cancer Center, Hackensack Meridian Health, Hackensack, New Jersey, USA.
  • Rowley S; John Theurer Cancer Center, Hackensack Meridian Health, Hackensack, New Jersey, USA.
  • Donato M; John Theurer Cancer Center, Hackensack Meridian Health, Hackensack, New Jersey, USA.
  • Pecora AL; John Theurer Cancer Center, Hackensack Meridian Health, Hackensack, New Jersey, USA.
  • Richter J; Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Anand P; John Theurer Cancer Center, Hackensack Meridian Health, Hackensack, New Jersey, USA.
  • McBride L; John Theurer Cancer Center, Hackensack Meridian Health, Hackensack, New Jersey, USA.
  • Ivanovski K; John Theurer Cancer Center, Hackensack Meridian Health, Hackensack, New Jersey, USA.
  • Korngold R; Center for Discovery & Innovation, Hackensack Meridian Health, Institute for Multiple Myeloma, Hackensack, New Jersey, USA.
  • Siegel DS; John Theurer Cancer Center, Hackensack Meridian Health, Hackensack, New Jersey, USA.
Am J Hematol ; 96(11): E430-E433, 2021 11 01.
Article em En | MEDLINE | ID: mdl-34435374

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Dexametasona / Protocolos de Quimioterapia Combinada Antineoplásica / Anticorpos Monoclonais Humanizados / Lenalidomida / Mieloma Múltiplo Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies Limite: Humans Idioma: En Revista: Am J Hematol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Dexametasona / Protocolos de Quimioterapia Combinada Antineoplásica / Anticorpos Monoclonais Humanizados / Lenalidomida / Mieloma Múltiplo Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies Limite: Humans Idioma: En Revista: Am J Hematol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos